Invention Grant
- Patent Title: Engineered nucleases, compositions, and methods of use thereof
-
Application No.: US18348948Application Date: 2023-07-07
-
Publication No.: US12054756B2Publication Date: 2024-08-06
- Inventor: Xiao Yang , Lei S. Qi , Vincent Cutillas , Gabriella Alvarez , Tabitha Tcheau , Daniel O. Hart
- Applicant: Epicrispr Biotechnologies, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Epicrispr Biotechnologies, Inc.
- Current Assignee: Epicrispr Biotechnologies, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: KNOBBE, MARTENS, OLSON & BEAR, LLP
- Main IPC: C12N9/22
- IPC: C12N9/22 ; C12N15/11 ; C12N15/90
Abstract:
The present disclosure provides one or more engineered nucleases and systems, compositions, and methods thereof, wherein the one or more engineered nucleases can be used to effect binding, cleaving, and/or editing a target polynucleotide sequence. The one or more engineered nucleases can be engineered variants of a small CRISPR/Cas protein.
Public/Granted literature
- US20240035009A1 ENGINEERED NUCLEASES, COMPOSITIONS, AND METHODS OF USE THEREOF Public/Granted day:2024-02-01
Information query
